Vimarsana
Biggest News Aggregation in the World

Page 21 - Corresponding Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Corresponding Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Corresponding Author Today - Breaking & Trending Today

Researchers discover a new and unconventional nuclear function for cancer microRNA - Vimarsana News

Researchers discover a new and unconventional nuclear function for cancer microRNA

MicroRNAs (miRNA), non-coding RNA molecules, are widely known for regulating mRNA stability and translation. miR-10b has been increasingly implicated in the pathogenesis of gliomas, cancers of the brain.

Robotic Armband Enables Better Dexterity of Prosthetic Hands - Vimarsana News

Robotic Armband Enables Better Dexterity of Prosthetic Hands

For prosthetic hand users, pressing buttons on a remote control, typing on a keyboard, or braiding a child’s hair has remained elusive.

Improving the Object Detection Ability of Artificial Intelligence - Vimarsana News

Improving the Object Detection Ability of Artificial Intelligence

Researchers at North Carolina State University have developed a new system dubbed MonoCon that enhances the ability of object detection of artificial intelligence (AI) programs using 2D images.

Study simulates transmission of SARS-CoV-2 in airliner cabins - Vimarsana News

Study simulates transmission of SARS-CoV-2 in airliner cabins

A study published in Indoor Air simulated the transmission of SARS-CoV-2, the virus that causes COVID-19, on a flight from London to Hanoi and on another flight from Singapore to Hangzhou.

Independent drug action responsible for greater clinical efficacy of combination cancer therapies - Vimarsana News

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

Independent drug action, not synergy nor additivity, accounted for the clinical efficacy of nearly all examined combination therapies involving immune checkpoint inhibitors in clinical trials, according to results from a retrospective analysis.